SIC 5122 - Drugs, Drug Proprietaries, And Druggists' Sundries
Establishments primarily engaged in the wholesale distribution of prescription drugs, proprietary drugs, druggists'sundries, and toiletries. Establishments primarily engaged in the wholesale distribution of surgical, dental, and hospital equipment are classified in Industry 5047.
Industry trends:
The Drugs, Drug Proprietaries, and Druggists' Sundries industry, classified under SIC 5122, is experiencing significant transformation driven by several qualitative trends as we step further into the digital and personalized healthcare era. One primary trend is the increasing emphasis on personalized medicine, with advancements in genomics and biotechnology paving the way for treatments tailored to individual genetic profiles. This shift not only enhances therapeutic outcomes but also reduces adverse reactions, setting new standards for patient care.
Another substantial development is the integration of artificial intelligence and machine learning technologies within drug discovery and development processes. These innovations enable more efficient data analysis, expediting the identification of potential drug candidates and streamlining clinical trials. As a result, pharmaceutical companies are increasingly adopting AI to improve their R&D productivity and reduce time-to-market.
Further, the industry is witnessing a surge in demand for digital health solutions, including telemedicine, e-prescriptions, and mobile health apps, which are becoming integral in drug distribution and patient engagement. The COVID-19 pandemic has accelerated this trend, demonstrating the viability and necessity of remote healthcare options.
Looking ahead, the forecast for the near future suggests a continued trajectory towards greater digitalization and personalization. Regulatory bodies are expected to adapt to these changes, fostering an environment that supports innovation in drug approval processes and data-driven health solutions. Additionally, as sustainability becomes a core business imperative, pharmaceutical companies are likely to adopt greener practices, focusing on reducing environmental impact throughout the drug lifecycle. Overall, these trends indicate a paradigm shift towards a more agile, personalized, and environmentally conscious pharmaceutical industry.
This industry is comprised of:
Antiseptics-wholesale
Bandages-wholesale
Biologicals and allied products-wholesale
Blood plasma-wholesale
Cosmetics-wholesale
Drug proprietaries-wholesale
Druggists'sundries-wholesale
Drugs-wholesale
Hair preparations-wholesale
Medical rubber goods-wholesale
Medicinals and botanicals-wholesale
Medicine cabinet sundries-wholesale
Patent medicines-wholesale
Perfumes-wholesale
Pharmaceuticals-wholesale
Proprietary (patent) medicines-wholesale
Razor blades-wholesale
Razors, nonelectric-wholesale
Toilet articles-wholesale
Toilet preparations-wholesale
Toilet soap-wholesale
Toothbrushes, except electric-wholesale
Vitamins-wholesale
This report includes the ability to segment your Industry by:
- Region
- Employees
- Net Sales
- Company Age
- Total Assets
- Ownership Type
With iCFO You Get
What Is iCFO?
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Sound Business Analysis
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
Your Business’ Health In Minutes
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.